|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||28.82 - 30.52|
|52 Week Range||26.26 - 57.20|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 28, 2022 - Apr 01, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||65.17|
Today we’re looking at some micro-cap stocks to buy now and go long on hope. Apollo Medical (AMEH): Leadership has its privileges. Protagonist Therapeutics (PTGX): Behind solid execution comes long-term success. RadNet (RDNT): Rinse and repeat performance is approaching. Avid Bioservices (CDMO): Stabilization outlook is likely. Celldex Therapeutics (CLDX): It’s a technical thing. Castle Biosciences (CSTL): It’s a spending thing. MYR Group MYRG (MYRG): A true locomotive with a bunch of momentum.
Celldex Therapeutics, Inc. ( NASDAQ:CLDX ) shareholders have seen the share price descend 16% over the month. But that...
Celldex (CLDX) delivered earnings and revenue surprises of -6.52% and 76.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?